Home › Kanser sa Tiyan › California › Orange
Pag-aaral pangklinika para sa Kanser sa Tiyan sa Orange, CA
Isang pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orange. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Nagre-recruitPhase 2
- Research Site, Orange
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Nagre-recruitPhase 2/3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- UC IRVINE Health, Orange
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Nagre-recruitPhase 3
- Research Site, Orange
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Nagre-recruitObservasyonal na pag-aaral
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Nagre-recruitPhase 1
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Nagre-recruitPhase 2
- University of California, Irvine, Orange
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Stern Center for Cancer Clinical Trials and Research, Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Orange
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Nagre-recruitPhase 1/2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Pag-aaral para sa Kanser sa Tiyan sa ibang lungsod
- Houston, TX42 pag-aaral
- Boston, MA32 pag-aaral
- New York City, NY31 pag-aaral
- Nashville, TN28 pag-aaral
- Baldwin Park, CA22 pag-aaral
- Los Angeles, CA22 pag-aaral
- Arlington, VA20 pag-aaral
- Dallas, TX19 pag-aaral
- San Antonio, TX19 pag-aaral
- St. Louis, MO18 pag-aaral
- Grand Rapids, MI18 pag-aaral
- Washington, DC16 pag-aaral
Iba pang pag-aaral sa Orange
- Non-Small Cell Lung Cancer25 pag-aaral
- Metastatic Cancer20 pag-aaral
- Colorectal Cancer16 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Melanoma14 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)14 pag-aaral
- Kanser sa Suso14 pag-aaral
- Kanser sa Baga14 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Kanser (lahat ng uri)13 pag-aaral
- Acute Myeloid Leukemia13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.